🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 08205P209 (prev. 08205P100 )
- Market Cap
- Micro Cap
- Previous Name
- Benitec Biopharma Ltd
Business: Benitec Biopharma Ltd. is a clinical-stage biotechnology firm that has a proprietary therapeutic technology platform in development which combines gene silencing and gene therapy with the goal of providing sustained, long-lasting silencing of disease-causing genes from a single administration. The company specializes in RNA interference technology, or RNAi, the subject of a Nobel Peace Prize several years ago.
Notes: November 18, 2019 -- Benitec Biopharma Limited ("Benitec" or the "Company") (ASX:BLT; NASDAQ:BNTC; NASDAQ:BNTCW) has its ordinary shares ("Shares") listed on the ASX and American Depositary Shares ("ADSs") listed on The Nasdaq Capital Market. Each ADS represents a certain number of Shares. Benitec has announced a 10:1 ratio change of the Company’s American Depositary Receipt program from 1 ADS representing 20 Shares to a new ratio of 1 ADS representing 200 Shares. This ratio change will be effective as of 18 November 2019 (US time).The effect of the change in the ADS ratio is that the number of ADSs on issue will reduce to a number equal to 1/10 of the ADSs on issue prior to the change in ADS ratio, however the total number of Shares represented by the ADSs will remain the same.
Company Contact
- CEO
- Jerel A Banks
- CFO
- Megan Boston
- Headquarters
- 3940 Trust Way, Hayward, CA 94545
- Phone
- 510-780-0819
- Investor Relations
- Irina Koffler, LifeSci Advisors · 646-970-4681 · ikoffler@lifesciadvisors.com